Navigation Links
Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
Date:10/28/2008

OSLO, October 28 /PRNewswire-FirstCall/ -- DiaGenic ASA (OSL:DIAG) today announced that it has signed a service provider agreement with DNAVision, a leading panEuropean provider of gene expression-based diagnostic testing and services With this laboratory service and following CE marking scheduled in early2009, DiaGenic will be able to offer healthcare providers and patients in Europe its innovative blood-based gene-expression diagnostic test for early detection of breast cancer and Alzheimer's disease in a CLIA/ISO17025 certified environment.

"This agreement with DNAVision will provide us with the ideal launch platform across Europe for our blood-based tests for early detection of breast cancer and Alzheimer's disease," said DiaGenic CEO Erik Christensen, M.D., Ph.D., "We are currently introducing the breast cancer test in India. The key advantages of our tests are the ease of sample collection and the ability to detect the earliest signs of disease. However, quality control is equally important in generating provider and patient confidence. We therefore regard DNAVision as an ideal partner since their testing facilities for molecular diagnostics comply with the most advanced quality standards in Europe."

"We are delighted to provide the diagnostic testing arm for DiaGenic in Europe for their breast cancer and Alzheimer's disease tests. We are convinced that such tests are laying the basis for new levels of diagnostic services that will benefit overall healthcare provision in Europe " said Jean-Pol Detiffe, CEO of DNAVision. "This agreement is also continuing confirmation that DNAVision has become the partner of choice for biotech companies who want to step into the diagnostic market without facing long IVD application procedures, but with the help of a quality certified service provider generating data available for clinical and diagnostic purposes."

"In parallel to this agreement, we are finalizing marketing in preparation for a full Egy" timex="10/28/2008 11:36:55 AM" dirsub="( OSLO October 28 /- DiaGenic ASA (...)" id="8666" index="biology" dir="Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests" dir2="Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression B..." keywords1=",biological,advanced biology technology,biology laboratory technology,biology device technology,latest biology technology" keywords="Diagenic,Partners,With,DNAVision,to,Offer,First,Breast,Cancer,and,Alzheimers,Gene-Expression,Blood,Tests" description="... OSLO October 28 /- DiaGenic ASA (OSL:DIAG)... This agreement with DNAVision will provide us with the ideal launchp... We are delighted to provide the diagnostic testing arm for DiaGenic i... In parallel to this agreement we are finalizing marketing inprepara..." url=u&"/biology-technology-1/Diagenic-Partners-With-DNAVision-to-Offer-First-Breast-Cancer-and-Alzheimers-Gene-Expression-Blood-Tests-8666-2/" title="Diagenic%20Partners%20With%20DNAVision%20to%20Offer%20First%20Breast%20Cancer%20and%20Alzheimers%20Gene-Expression%20Blood%20Tests" %> Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression B... ( OSLO October 28 /- DiaGenic ASA (...)

Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
Date:10/28/2008

uropean launch early next year following CE marking of both the breast cancer and Alzheimer's test," concluded Dr Christensen.

About DiaGenic ASA

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for early detection of diseases. DiaGenic is currently a world leader in analyzing gene expression signatures related to disease in easily available clinical samples such as peripheral blood. This unique method is based on the principle that even when a disease is localized at a specific part of the body, secondary responses, which are also characteristic of the disease, can be measured in other parts. Significant potential in numerous diseases such as breast cancer and Alzheimer's disease has been identified. The company has been granted patents in the U.S. and Europe. DiaGenic is listed on the Oslo Stock Exchange. For more information visit http://www.diagenic.com

About DNAVision

DNAVision is a leading provider of applied pharmacogenetic & pharmacogenomic services.

DNAVision offers the powerful combination of different technologies in expression profiling, SNP genotyping and sequencing in a high quality environment (First European laboratory to be ISO17025 accredited). DNAVision is a spin-off of University of Brussels and Institute of Pathology and Genetics. More information on DNAVision's service portfolio can be found on http://www.dnavision.com

Corporate Inquiries: Erik Christensen, Managing Director DiaGenic ASA, Grenseveien 92, NO-0663 Oslo, Norway, Tel +47-95939918, Email: erik.christensen@diagenic.com; Media Inquiries: For DNAVision: Michael Herman, DNAVision, Tel +32-71378527, Email m.herman@dnavision.com


'/>"/>
SOURCE DiaGenic ASA
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
2. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
4. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
5. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
7. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
8. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
9. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
10. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Margot Connor, CEO ... on Baltimore Business Journal’s 2017 Tech 10 List of “outstanding professionals in the ... for contributions to the technology industry within their local community. Honorees are “CEOs ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... (AI) and leading supplier of Semantic Graph Database technology for Knowledge Graphs, today ... and discovering connections within data. Gruff provides novice users and graph experts the ...
(Date:7/26/2017)... , ... July 25, 2017 , ... ... proud to announce that its regenerative stem cell therapy has been used on ... a successful treatment for horses with potentially fatal injuries to tendons and ligaments. ...
(Date:7/26/2017)... Minneapolis, MN (PRWEB) , ... July 26, 2017 ... ... All of Us Research Program at the National Institutes of Health (NIH), will ... Medicine Conference. This annual conference provides a platform for a multi-stakeholder discussion on ...
Breaking Biology Technology:
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Biology News(10 mins):